GlassScriptPhysician profile
Bradley W Wargo
NPI 1447241021
$40,630.71
in general payments reported to CMS, 2019-2025
23 companies · $31K in 2025
The $31K reported for 2025 was more than what 98% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $6,863 · 2021: $344 · 2022: $1,307 · 2023: $304 · 2024: $171 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $4,596 · Food and Beverage: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,217.50 |
| Travel and Lodging | $4,596.10 |
| Food and Beverage | $1,956.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $30,541.66 | 2025 | |
| Gentleman Orthopedic Solutions | $3,927.59 | 2020 | |
| Arthrex, INC. | $2,596.49 | 2020 | |
| Nevro Corp. | $1,042.98 | 2019-2024 | Senza |
| Abbott Laboratories | $868.09 | 2020-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $406.62 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $261.43 | 2021-2022 | |
| Grt US Holding, INC. | $234.21 | 2022 | |
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceutical Holding Company LTD. | $138.19 | 2022 | |
| Stimwave Technologies Incorporated | $68.49 | 2022 | |
| Stryker Corporation | $58.88 | 2020-2025 | Mild Device Kit |
| Biotronik Nro, INC. | $56.01 | 2025 | Prospera |
| Spr Therapeutics, INC | $51.10 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $42.20 | 2022-2023 | Livalo, Seglentis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $35.33 | 2025 | Evoke |
| Relievant Medsystems, INC. | $32.36 | 2022 | |
| Collegium Pharmaceutical, INC. | $29.56 | 2022 | |
| Mml US, INC. | $24.05 | 2025 | Reactiv8 |
| Nalu Medical, INC. | $20.39 | 2022 | |
| Scilex Pharmaceuticals INC. | $20.00 | 2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.31 | 2022 | |
| Horizon Therapeutics Plc | $16.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Wargo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.